Payal Tiwari
About Payal Tiwari
Payal Tiwari is a Postdoctoral Scholar currently working at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. She has a background in Oncology and Cancer Biology, holding a PhD from the University of Chicago and has previously worked at several research institutions.
Work at Broad Institute
Payal Tiwari has been serving as a Postdoctoral Scholar at the Broad Institute of MIT and Harvard since 2019. In this role, she conducts research in the field of cancer biology, contributing to various projects aimed at understanding cancer mechanisms and developing potential therapeutic strategies. The Broad Institute is known for its collaborative approach and cutting-edge research, providing an environment conducive to scientific innovation.
Work at Dana-Farber Cancer Institute
In addition to her role at the Broad Institute, Payal Tiwari has been a Postdoctoral Scholar at Dana-Farber Cancer Institute since 2018. Her work at Dana-Farber focuses on cancer research, where she engages in projects that aim to advance the understanding of cancer treatment and patient care. Dana-Farber is recognized for its commitment to cancer research and patient care, making it a significant institution in the field.
Education and Expertise
Payal Tiwari completed her Doctor of Philosophy (PhD) in Oncology and Cancer Biology at the University of Chicago from 2012 to 2018. Prior to her PhD, she earned a Master of Science (MS) in Biology with a specialization in Cell and Molecular Biology from the Illinois Institute of Technology from 2008 to 2010. She also holds a Bachelor of Technology (B.Tech) in Biotechnology from DCRUST, completed from 2004 to 2008. Her educational background provides a strong foundation in biological sciences and cancer research.
Previous Work Experience
Before her current positions, Payal Tiwari worked at The University of Chicago as a Research Specialist in Dr. Ernst Legyel's laboratory from 2009 to 2012. She also served as a Research Associate at the IIT Research Institute for 11 months in 2009. Her experience at these institutions contributed to her expertise in research methodologies and cancer biology, shaping her career in the scientific community.